![Francis Cuss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francis Cuss
Direktor/Vorstandsmitglied bei
Montclair State University
Profil
Francis M.
Cuss is currently Vice Chairman at Montclair State University and Director at Novo Holdings A since 2017.
Former positions include Independent Director at Rubius Therapeutics, Inc. from 2018 to 2023, Director at Glympse Bio, Inc. from 2019 to 2023, Independent Director at Mural Oncology Plc from 2023 to 2025, Senior VP-Biology & Early Clinical Research at Schering-Plough Corp.
from 1989 to 2003, Principal at GlaxoSmithKline LLC, and Chief Scientific Officer & Executive VP at Bristol Myers Squibb Co. from 2013 to 2017.
Education includes a doctorate from the University of Cambridge.
Aktive Positionen von Francis Cuss
| Unternehmen | Position | Beginn |
|---|---|---|
Montclair State University
 Montclair State University Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Direktor/Vorstandsmitglied | 01.09.2017 |
Ehemalige bekannte Positionen von Francis Cuss
| Unternehmen | Position | Ende |
|---|---|---|
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Direktor/Vorstandsmitglied | 01.04.2023 |
| RUBIUS THERAPEUTICS | Direktor/Vorstandsmitglied | 31.01.2023 |
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2017 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Francis Cuss
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
81
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Montclair State University
Montclair State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Health Technology |
